Last updated: March 19, 2018

Ex-drug executive Shkreli to face U.S. fraud trial in June 2017

NEW YORK (Reuters) – Martin Shkreli, the former pharmaceutical executive who last year became a lightning rod for criticism of soaring prescription drug prices, is now scheduled to go on trial in June 2017 in the U.S. government’s securities fraud case against him.

Reuters: U.S.

Keywords: , , , , , , , ,

Readers Comments (0)

Sorry, comments are closed on this post.

Recent Posts

Have You Read?

Video News